Labcorp Holdings IncNYSE:LH
- LAST PRICE222.2200
- TODAY'S CHANGE (%)-2.3700 (-1.0553%)
- Bid / Lots211.6300/ 1
- Ask / Lots233.3200/ 2
- Open / Previous Close223.3800 / 224.5900
- Day Range
- 52 Week Range
- Volume894,372
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Yesterday
DJ Laboratory Corp. Is Maintained at Outperform by Baird, from 7:31AM ET on Friday Sep 20, 2024 by Dow Jones
7:31AM ET on Friday Sep 20, 2024 by Dow Jones
Sep 18, 2024
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience, from 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 16, 2024
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034, from 6:35PM ET on Monday Sep 16, 2024 by Dow Jones
6:35PM ET on Monday Sep 16, 2024 by Dow JonesPress Release: Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health, from 7:30AM ET on Monday Sep 16, 2024 by Dow Jones
7:30AM ET on Monday Sep 16, 2024 by Dow JonesLabcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health, from 7:30AM ET on Monday Sep 16, 2024 by Dow Jones
7:30AM ET on Monday Sep 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Labcorp Holdings Inc | 18.9B | 42.2x | -13.71% |
Quest Diagnostics Inc | 17.3B | 20.6x | +7.78% |
Universal Health Services Inc | 15.7B | 17.5x | +4.42% |
DaVita Inc | 13.7B | 17.5x | +15.72% |
Tenet Healthcare Corp | 16.0B | 6.0x | +41.18% |
Healthpeak Properties Inc | 15.4B | 47.4x | -20.31% |
Company Information
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.
Contact Information
- Headquarters
- 358 S Main StBURLINGTON, NC, United States 27215
- Phone
- 336-229-1127
- Fax
- 302-636-5454
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $18.7B |
|---|---|
Revenue (TTM) | $12.5B |
Shares Outstanding | 84.0M |
Dividend Yield | 1.30% |
Annual Dividend Rate | 2.8800 USD |
Ex-Dividend Date | 08-29-24 |
Pay Date | 09-13-24 |
Beta | 1.06 |
EPS | $5.26 |
Book Value | $93.86 |
P/E Ratio | 42.2x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | 17.7x |
Operating Margin | 5.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
